¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"Cancer Chemother Biol Response Modif"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
integrated cancer management
ÅëÇÕ¾ÏÄ¡·á
laryngeal cancer
ÈĵξÏ
liver cancer
°£¾Ï
medullary cancer
¼ÓÁú¾Ï, ¼öÁú¾Ï
metastatic cancer
ÀüÀ̾Ï
occult cancer
ÀáÀç¾Ï
occupational cancer
Á÷¾÷¾Ï
papillary cancer
À¯µÎ¸ð¾ç¾Ï
primary cancer
¿ø¹ß¾Ï
prostate cancer
Àü¸³»ù¾Ï, Àü¸³¼±¾Ï
prostatic cancer
Àü¸³»ù¾Ï, Àü¸³¼±¾Ï
recurrent cancer
Àç¹ß¾Ï
renal cancer
ÄáÆÏ¾Ï, ½ÅÀå¾Ï
radiation-induced cancer
¹æ»ç¼±À¯¹ß¾Ï
retrograde cancer
ÅðÇà¾Ï
ÀÌÀü
´ÙÀ½
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
14
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
cervical cancer
Àڱøñ¾Ï, ÀڱðæºÎ¾Ï
colon cancer
Àß·ÏâÀÚ¾Ï, °áÀå¾Ï
follicular cancer
¼ÒÆ÷¾Ï
gallbladder cancer
¾µ°³¾Ï
infiltrating cancer
ħÀ±¾Ï
inflammatory breast cancer
¿°ÁõÀ¯¹æ¾Ï
medullary cancer
¼ÓÁú¾Ï, ¼öÁú¾Ï
metastatic cancer
ÀüÀ̾Ï
primary cancer
¿ø¹ß¾Ï
prostatic cancer
Àü¸³»ù¾Ï
renal cancer
ÄáÆÏ¾Ï, ½ÅÀå¾Ï
thyroid papillary cancer
°©»ó»ùÀ¯µÎ¾ÏÁ¾
undifferentiated cancer
¹ÌºÐȾÏ
cancer pain
¾ÏÅëÁõ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
primary cancer
¿ø¹ß¾Ï
radiation-induced cancer
¹æ»ç¼±À¯¹ß¾Ï
recurrent cancer
Àç¹ß¾Ï
retrograde cancer
ÅðÇà¾Ï
small cell lung cancer
ÀÛÀº¼¼Æ÷ÇãÆÄ¾Ï, ¼Ò¼¼Æ÷Æó¾Ï
soft cancer
(¢¡medullary carcinoma) ¼ÓÁú¾ÏÁ¾, ¼öÁú¾ÏÁ¾
solid cancer
°íÇü¾Ï
integrated cancer management
ÅëÇÕ¾ÏÄ¡·á
alerting response
°¢¼º¹ÝÀÀ
anamnestic response
(¢¡secondary immune response) ÀÌÂ÷¸é¿ª¹ÝÀÀ
arousal response
°¢¼º¹ÝÀÀ
autoimmune response
ÀÚ°¡¸é¿ª¹ÝÀÀ
brainstem evoked response audiometry
³úÁÙ±âÀ¯¹ß¹ÝÀÀû·Â°Ë»ç
evoked response audiometry
À¯¹ß¹ÝÀÀû·Â°Ë»ç
galvanic skin response audiometry
ÇǺÎÀü±â¹ÝÀÀû·Â°Ë»ç
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
Inflammatory response
¿°Áõ¹ÝÀÀ(æúñøÚãëë)
Lewis triple response
·çÀ̽º »ïÁß ¹ÝÀÀ
MAC-BAR(minimum alveolar concentration-blockade of autonomic response)
ÀÚÀ²½Å°æ¾ïÁ¦ ÃÖ¼ÒÆóÆ÷³»³óµµ
allergic response
¾Ë·¹¸£±â¹ÝÀÀ, °ú¹Î¹ÝÀÀ
analytical response detection
ºÐ¼®¹ÝÀÀ°¨Áö
antibody response
Ç×ü¹ÝÀÀ(¡Úãëë).
approximate response
±Ù»ç¹ÝÀÀ
arousal reaction=arousal response
°¢¼º¹ÝÀÀ(ÊÆá¥Úãëë)
frenquency response curve
Á֯ļö ¹ÝÀÀ°î¼±
galvanic skin response =GSR
Àü±âÇǺιÝÀÀ(ï³Ñ¨ù«Ý±Úãëë).
galvanic skin response audiometry
ÇǺÎÀü±â¹ÝÀÀ û·Â°Ë»ç
heat shock response
¿Ãæ°Ý¹ÝÀÀ
ideosyncratic drug response
ƯÀ̼º ¾à¹° ¹ÝÀÀ
immune response
¸é¿ªÀÀ´ä.
immune response
¸é¿ª¹ÝÀÀ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
cancer suppressor genes
¾Ï¾ïÁ¦À¯ÀüÀÚ(äßåäð¤ë¶îîí)
cancer,grading and staging
µî±Þ(ÔõÐä)°ú º´±â °áÁ¤(ܻѢ̽ïÒ)
cauliflower cancer
²É¾ç¹èÃß»ó¾Ï, ¹èÃ߸ð¾ç¾Ï
cauliflower cancer
Á¼ÀÍ
cervical cancer
ÀڱðæºÎ¾Ï
conjugal cancer
ºÎºÎ¾Ï(ÜýÜþäß).
corset cancer
ÄÚ¸£¼Â¾Ï(¡äß).
corset cancer
ÄÚ¸£¼Â ¾Ï(¡äß).
cuirass cancer
ÈäºÎ°æÈÀüÀ̼º À¯¾Ï(ýØÝ»Ìãûùï®ì¹àõêáäß), Èä°©¾Ï.
cuirass cancer
ÈäºÎ(ÀüÀ̼º)ÇǺξÏ(ÈäºÎÀüÀ̼ºÇǺξÏ).
cutaneous cancer
ÇǺξÏ(ù«Ý± )
duct cancer
°ü¾Ï(°ü¾Ï).
early cancer
Á¶±â¾Ï(ðÄÑ¢äß).
early cancer
Á¶±â¾Ï(Á¶±â¾Ï).
early gastric cancer
Á¶±âÀ§¾Ï.
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½